The syringe slimming brand “Wegova” is sold at Achat in Mitte. The “Wegova” slimming syringe has been available in Germany for a year.
Jens Kalaene Picture Alliance Getty images
Novo Nordisk On Tuesday he said that he would offer a drug for slimming Wegova by Sophia suppliers Him and her healthIN Ro and Lifemd to expand access to hit treatment now, when he is no longer able to get in the USA
Hims and her actions increased on Tuesday by 18%, and Novo Nordisk supplies increased by 3%.
The Danish drug manufacturer is racing to capture more patients when many pharmacies are legally limited to creating cheaper, unapproved versions Wegovawith rare exceptions. Patients gathered to these complex versions, while Wegova was missing because of a rapid increase in demand.
“We thought that hard work is very important to establish cooperation with Teradrowia companies so that there could be access to Wegova when he is complex,” said CNBC Dave Moore, Vice President for Operation Operation at the USA at Novo Nordisk.
“We are very pleased with the level of interest in access to the Wegova brand and starting catching people who come out of complex medicine,” he said.
Moore added that new partnerships make experience “trouble -free” to patients, because it allows them to access Wegova straight from teeth supplier, which “makes it very easy” to provide the drug directly to their homes.
Patients will be able to access the new Novo Nordisk online pharmacy, directly to the consumer, Novocaredirectly by Telehealth suppliers.
This pharmacy offers Wegova for 499 USD in cash per month – about half of its ordinary monthly catalog price – for patients without insurance for a weekly injection.
The price of every Sofa company can be higher because they probably contain additional services, said Novo Nordisk CNBC spokesman.
Novo Nordisk Annual stock exchange chart
Hims and Hers said that it would start to offer all Wegova doses along with access to 24/7 care, nutrition tips and continuous clinical support this week, starting from 599 USD per month for qualifying patients paid cash with a prescription.
Drugs will cost Him and Her clients more because it has additional access to care, said CNBC, company general director, Andrew Dudum. He said he believes that the company's partnership from Novo Nordisk would serve as a case study, how patients gain access and receive prices of “great medicine” and other forms of treatment.
RO decided to a lower price, announcing on Tuesday that he would offer access to all Wegova doses for USD 499 per month. The company provides 24/7 messages, one -on -one coaching, educational content and many others through a monthly membership called The Body Program, which does not include the cost of drugs.
“The addition of treatment approved by the FDA Novo Nordisk at the best available cash price will help more patients throughout the country to obtain the care of obesity needed to achieve their goals, especially those without insurance,” said the CEO of Ro Zach Reitano in a communiqué.
At the beginning of this month, Him and her announced that patients could access Eli LillyDrugs for slimming Zepbound and a drug for diabetes Mounjaroas well as general injection lyrraglutide through its platform. But unlike the company's cooperation with Novo Nordisk, Lilly issued a statement explaining that “there is no connection” with Hims and her.
Him and her began to prescribe a complex semaglutide, an active ingredient in Novo Nordisk“Diabetes Drug Ozempic and Wegova, in May 2024, the company largely had to stop offering complex drugs, but some consumers may still have access to personalized doses, if it is clinically applied, said Dudum.
“It was one of the first things that we shared with Novo is that we will always fight on behalf of what consumers, which we think have the right to get,” said Dudum. “The regulation is very clear.”
While Decroda Food and Drug deficienciesPharmacists can legally create complex versions of branded drugs. They can also be produced individually when it is medically necessary for the patient, for example, when they cannot swallow the pill or are allergic to a specific component of a branded medicine.
But drug producers and some health experts have pushed the practice to practice, mainly because the FDA does not approve of complex drugs.
Larger, federally regulated complex pharmacies that produce copies of semaglutide without a prescription, become a legal date on May 22 to stop marketing and selling these versions. A smaller, licensed state of complex pharmacies, which are produced by semaglutide followers for individual prescriptions, had a period of April 22.
“The spirit of this is that we remain faithful to what the rules are,” said Moore. “This is the best way to handle patients.”
– Brandon Gomez and Angelica Peebs from CNBC contributed to this report.